HARRISON F. WOOD, M.D.; HENRY D. DIAMOND, M.D., F.A.C.P.; LLOYD F. CRAVER, M.D., F.A.C.P.; ELMER PADER, M.D.; SAMUEL K. ELSTER, M.D.
Since the first description of C-reactive protein by Tillett and Francis in 1930, the occurrence of this substance, which is not present in the blood of normal individuals, has been noted by many workers in a wide variety of disorders.1-4 The first extensive clinical study of C-reactive protein in a specific disease was that of Anderson and McCarty, who found, in a group of 45 patients with acute rheumatic fever, that the determination for this acute phase protein provided a sensitive and useful index of the activity of the disease process.5 Their findings have since been confirmed by other groups,
WOOD HF, DIAMOND HD, CRAVER LF, PADER E, ELSTER SK. DETERMINATION OF C-REACTIVE PROTEIN IN THE BLOOD OF PATIENTS WITH HODGKIN'S DISEASE(DETERMINATION OF C-REACTIVE PROTEIN IN THE BLOOD OF PATIENTS WITH HODGKIN'S DISEASE*). Ann Intern Med. 1958;48:823–833. doi: 10.7326/0003-4819-48-4-823
Download citation file:
Published: Ann Intern Med. 1958;48(4):823-833.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use